Articles of the Month
Videos
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Articles
IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis
Maintz, L., Welchowski, T., Herrmann, N., et al. Allergy. First published: 17 January 2023
Fatal and near-fatal anaphylaxis: the Allergy-Vigilance® Network data (2002-2020)
Pouessel, G., Alonzo, S., Divaret-Chauveau, A., Dumond, P., et al. Allergy. First published: 16 January 2023
Detergent-induced eosinophilic inflammation in the esophagus: A key evidence for the Epithelial Barrier Theory
Yazici, D., Pat, Y., Mitamura, Y., Akdis, C.A. and Ogulur, I. Allergy. First published: 16 January 2023
The Molecular Allergology User's Guide version 2.0 is freely available!
Hoffmann-Sommergruber, K., Santos, A.F. and Breiteneder, H. Allergy. First published: 12 January 2023
Early infancy dysbiosis in food protein-induced enterocolitis syndrome: a prospective cohort study
Su, K.-W., Cetinbas, M., Martin, V.M., et al. Allergy. First published: 12 January 2023
Severe cutaneous adverse reactions after covid-19 vaccination: A systematic review
Wu, P.-C., Huang, I.-H., Wang, C.-W., Chung, W.-H. and Chen, C.-B. Allergy. First published: 10 January 2023
Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Kim, J., Kim, B.E., Berdyshev, E., et al. Allergy. First published: 07 January 2023
Berotralstat for the prophylaxis of hereditary angioedema – Real world evidence data from the United Kingdom
Ahuja, M., Dorr, A., Bode, E., et al. Allergy. First published: 07 January 2023
Angiomotin and angiostatin as asthma biomarkers: implications for the regulation of airway remodeling and inflammation
Lee, P.-H., Choi, S., An, M., et al. Allergy. First published: 05 January 2023
Overall and respiratory mortality reduction with physical activity in subjects with and without asthma
Lee, H., Ryu, J., Chung, S.J., et al. Allergy. First published: 05 January 2023
Association of fracture incidence in children with the development of food allergy: A Korean nationwide birth cohort study
Kwon, R., Shin, Y.H., Shin, J.I., et al. Allergy. First published: 05 January 2023
Autologous Th2-polarized lymphocytes induce atopic dermatitis lesions in non-atopic human skin xenotransplants
Keren, A., Reich, K., Bertolini, M., et al. Allergy. First published: 04 January 2023
Respiratory virome profiles reflect antiviral immune responses
Rubió, J.R., Megremis, S., Pasioti, M., et al. Allergy. First published: 03 January 2023
How does particulate air pollution affect barrier functions and inflammatory activity of lung vascular endothelium?
Olesiejuk, K. and Chałubiński, M. Allergy. First published: 01 January 2023
An artificial intelligence algorithm-based smartphone application for daily cough monitoring
Shim, J.-S., Kim, M.-H., Lee, S.M., et al. Allergy. First published: 01 January 2023
A compilation answering 50 questions on Monkeypox virus and the current Monkeypox outbreak
Cabanillas, B., Murdaca, G., Guemari, A., et al. Allergy. First published: 01 January 2023
Importance of examining atopic dermatitis disease mechanisms in African populations
Lunjani, N., Akdis, C.A. and O'Mahony, L. Allergy. First published: 28 December 2022
Introduction of General Chapters on standard methods for allergen quantification in the European Pharmacopoeia
Zimmer, J., Bonertz, A., Kaul, S. and Vieths, S. Allergy. First published: 28 December 2022
Editorial comments on “Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants – The STOP-AD randomized controlled trial” – is emollient therapy enough?
Brough, H.A., Sindher, S. and Nadeau, K.C. Allergy. First published: 27 December 2022
IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma
Bajbouj, K., AbuJabal, R., Sahnoon, L., et al. Allergy. First published: 27 December 2022
Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals
Mota, D., Rama, T.A. and Moreira, A. Allergy. First published: 26 December 2022
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2
Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022
Oral immunotherapy for food allergy: what's age got to do with it?
Upton, J.E.M., Correa, N. and Eiwegger, T. Allergy. First published: 20 December 2022
Deciphering the role of platelets in severe allergy by an integrative omics approach
Pablo-Torres, C., Izquierdo, E., Tan, T.J., et al. Allergy. First published: 17 December 2022
A gene variant of AKR1C3 contributes to interindividual susceptibilities to atopic dermatitis triggered by particulate air pollution
Vogeley, C., Kress, S., Lang, D., et al. Allergy. First published: 16 December 2022
Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit
Dorr, A.D., Chopra, C., Coulter, T.I., et al. Allergy. First published: 12 December 2022
Reduced intra-subject variability of an automated skin prick test device compared to a manual test
Gorris, S., Uyttebroek, S., Backaert, W., et al. Allergy. First published: 10 December 2022
Different phenotypes of drug-induced anaphylaxis - data from the European Anaphylaxis Registry
Hanschmann, T., Francuzik, W., Dölle-Bierke, S., et al. Allergy. First published: 08 December 2022
Medical algorithm: Diagnosis and management of histaminergic angioedema
Ferrer, M., Rodriguez-Garijo, N. and Sabaté-Brescó, M. Allergy. First published: 08 December 2022
Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study
Céspedes, J.A., Fernández-Santamaría, R., Ariza, A., et al. Allergy. First published: 07 December 2022
PKCα interacts with Cav1.3 calcium channels to promote the Cav1.2/Cav1.3 duo tuning Th2 functions
Giang, N., Villeneuve, T., Maire, K., et al. Allergy. First published: 07 December 2022
Atopic dermatitis: The importance of future research in Africa
Fehr, D., Lang, C., Masenga, J., et al. Allergy. First published: 05 December 2022
Lactococcus lactis-derived microparticles ad mixed with allergen shift immune responses towards a regulatory profile in tree-nut allergic patients
Palomares, F., Mayorga, C., Leenhouts, K., et al. Allergy. First published: 04 December 2022
Intravenous immunoglobulins, cyclosporine and best supportive care in Epidermal Necrolysis: Diverse effects on systemic inflammation
Schmidt, V., Lalevée, S., Traidl, S., et al. Allergy. First published: 04 December 2022
Sounding the alarmins – the role of alarmin cytokines in asthma
Gauvreau, G.M., Bergeron, C., Boulet, L.-P., et al. Allergy. First published: 04 December 2022
Loss of PP4 contributes to DEP-induced epithelial barrier integrity disruption and alarmins release
Yang, F.-M., Hu, M.-C., Weng, C.-M., et al. Allergy. First published: 05 December 2022
Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with caecal microbiota changes
Alhamwe, B.A., Gao, Z., Alhamdan, F., et al. Allergy. First published: 02 December 2022
Systemic gene signature of inhaled corticosteroid treatment in allergic asthma to flour
Ndika, J., Suojalehto, H., Lindström, I., et al. Allergy. First published: 01 December 2022
Early-life fecal metabolomics of food allergy
Lee-Sarwar, K.A., Chen, Y.-C., Lasky-Su, J., et al. Allergy. First published: 30 November 2022
Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances
Kaplan, A., Lebwohl, M., Giménez-Arnau, A.M., et al. Allergy. First published: 30 November 2022
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Aranda, C.J., Gonzalez-Kozlova, E., Saunders, S.P., et al. Allergy. First published: 29 November 2022
COVID-19 pandemic and environment: Not only air pollution
Caminati, M., Guarnieri, G., Marchetti, P., et al. Allergy. First published: 28 November 2022
Basophil reactivity to BNT162b2 in COVID-19 convalescence
Perkins, G.B., Hurtado, P.R. and Hissaria, P. Allergy. First published: 28 November 2022
Reply to: “COVID-19 pandemic and environment: Not only air pollution.”
Fiorito, S., Soligo, M., Gao, Y., Ogulur, I., Akdis, C.A. and Bonini, S. Allergy. First published: 28 November 2022
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma
Alvarado-Vazquez, P.A., Cardenas, E.I., Das, A. and Hallgren, J. Allergy. First published: 27 November 2022
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
Logan, K., Bahnson, H.T., Ylescupidez, A., et al. Allergy. First published: 27 November 2022
Prepregnancy body mass index and risk of childhood asthma
Rosenquist, N.A., Richards, M., Ferber, J.R., et al. Allergy. First published: 27 November 2022
Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice
Musiol, S., Harris, C.P., Karlina, R., et al. Allergy. First published: 24 November 2022
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients
Spekhorst, L.S., van de Rijst, L.P., de Graaf, M., et al. Allergy. First published: 24 November 2022
Fenebrutinib and BTK inhibition: unveiling a new target for the treatment of chronic spontaneous urticaria
Carvallo, A., Sánchez-Fernández, S. and Morales-Palacios, M.P. Allergy. First published: 24 November 2022
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
Bet v 1-independent sensitization to major allergens in Fagales pollen: evidence at the T cell level
Polak, D., Vollmann, U., Grilo, J., et al. Allergy. First published: 24 November 2022
Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling
Bitting, K., Hedgespeth, B., Ehrhardt-Humbert, L.C., et al. Allergy. First published: 24 November 2022
GALTectomy increases the risk of allergic rhinitis: A nationwide population-based cohort study
Lin, T.-M., Hsu, H.-C., Shen, Y.-C., et al. Allergy. First published: 22 November 2022
Nutritional metabolites as biomarker for food intake to improve dietary-based randomized control trials
Venter, C. and Frei, R. Allergy. First published: 22 November 2022
Pest sensitization to cockroach, mouse, and rat: an Italian multicenter study
Liccardi, G., Maria Beatrice, B., Calzetta, L., et al. Allergy. First published: 18 November 2022
Frequent presence of major dust mite allergens in human digestive tissues of children with gastritis
Zhou, Y., Yang, S., Lin, Q., He, Q. and Cui, Y. Allergy. First published: 18 November 2022
RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity
Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes KITD816V in blood of mastocytosis and MCAS
Navarro-Navarro, P., Alvarez-Twose, I., Pérez-Pons, A., et al. Allergy. First published: 16 November 2022
Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022
Precision cut intestinal slices, a novel model of acute food allergic reactions
Hung, L., Celik, A., Yin, X., et al. Allergy. First published: 14 November 2022
Legends of Allergy and Immunology: Alberto Mantovani, a visionary scientist unraveling the complexity of innate immunity in cancer and inflammation
Moretta, L. and Sozzani, S. Allergy. First published: 13 November 2022
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: a systematic review
Broderick, C., Ziehfreund, S., van Bart, K., et al. Allergy. First published: 10 November 2022
Citations: 86
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 66
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 66
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 66
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 64
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper
Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628
Citations: 58
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 53
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313
Citations: 41
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377
Citations: 41
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 38
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775
Citations: 35
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!
Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920
Citations: 35
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 34
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion
Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117
Citations: 33
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 32
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881
Citations: 32
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339
Citations: 31
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641
Citations: 30
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2
Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
Diagnostic accuracy of vaccine and vaccine excpient testing in the setting of allergic reactions to covid-19 vaccines: a systematic review and meta-analysis
Greenhawt, M., Shaker, M., Golden, D.B.K., et al. Allergy. First published: 02 November 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
Kwasniewski, M., Korotko, U., Chwialkowska, K., et al. Allergy. First published: 21 September 2022
Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Junior Members,
ISMA-RHINA Digital 2022
The Food Allergy and Anaphylaxis meeting (FAAM) and the European Consortium on the Application of Flow Cytometry in Allergy (EUROBAT) was held between 1-3 December 2022 in an online format. More than 600 participants joined this exciting meeting, where experts from all over the world and young scientists discussed the latest data on food allergy, anaphylaxis and the usefulness of basophil and mast cell activation tests.
EAACI Junior Members played an important role throughout the event. During EUROBAT, Leticia de las Vecillas, chair of the EAACI Junior Members Assembly (JMA), presented an interesting poster related to the usefulness of the basophil activation test in Rivaroxaban allergy. In addition, Ruben Fernandez-Santamaria, JM representative for the Basic and Clinical Immunology Section, presented an oral abstract related to the basophil activation test and chemotherapeutic agents.
Junior members also played a key role during FAAM, with posters and oral presentations related to risk factors, prevention, mechanisms, immunotherapy, and clinical management of food allergy. It is worth mentioning the presentation by Carmen Riggioni, past chair of the JMA, who explained in depth and comprehensively the EAACI guidelines on the diagnosis of food allergy.
The JM assembly would like to congratulate and thank all the participants in this meeting, especially the junior members, whose work, scientific contribution, and enthusiasm significantly improve our specialty on a daily basis.
We look forward to seeing you at the next EAACI events!
Best regards,
The Junior Member Assembly
